,address1,address2,city,state,zip,country,phone,fax,website,industry,industryDisp,sector,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,shortRatio,shortPercentOfFloat,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToEbitda,52WeekChange,SandP52WeekChange,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,uuid,messageBoardId,gmtOffSetMilliseconds,currentPrice,recommendationMean,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,debtToEquity,returnOnAssets,returnOnEquity,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,373 Inverness Parkway,Suite 200,Englewood,CO,80112,United States,720 437 6500,720 437 6501,https://ampiopharma.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.",8,"{'maxAge': 1, 'name': 'Mr. Michael A. Martino', 'age': 65, 'title': 'CEO & Director', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 548141, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,4.17,4.18,4.0401,4.38,4.17,4.18,4.0401,4.38,0.0,1.779391,-47.444443,33065,33065,29213,47947,47947,4.11,4.4,800,1100,3224166,3.354,27.51,4.3597,5.003753,0.0,0.0,USD,-3314829,0.0,689270,755074,21291,13716,1690761600,1693440000,0.028199999,0.4,0.028900001,755074,8.687,0.49153906,1672444800,1703980800,1688083200,-13980000,-118.32,-0.09,1:20,1694476800,0.243,-0.83055556,0.14113986,ASE,EQUITY,AMPE,AMPE,"Ampio Pharmaceuticals, Inc.","Ampio Pharmaceuticals, Inc.",1270042200,America/New_York,EDT,4c3db42c-6886-3221-8b5a-40ddd23eb155,finmb_84650489,-14400000,4.27,3.0,hold,6987000,9.253,-13664000,448000,3.354,3.667,6.829,-0.49251997,-1.04888,-11049000,-15937000,0.0,0.0,0.0,USD,
1,373 Inverness Parkway,Suite 200,Englewood,CO,80112,United States,720 437 6500,720 437 6501,https://ampiopharma.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.",8,"{'maxAge': 1, 'name': 'Dr. David  Bar-Or M.D.', 'age': 73, 'title': 'Founder & Chairman of Scientific Advisory Board', 'yearBorn': 1949, 'fiscalYear': 2022, 'totalPay': 145604, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,4.17,4.18,4.0401,4.38,4.17,4.18,4.0401,4.38,0.0,1.779391,-47.444443,33065,33065,29213,47947,47947,4.11,4.4,800,1100,3224166,3.354,27.51,4.3597,5.003753,0.0,0.0,USD,-3314829,0.0,689270,755074,21291,13716,1690761600,1693440000,0.028199999,0.4,0.028900001,755074,8.687,0.49153906,1672444800,1703980800,1688083200,-13980000,-118.32,-0.09,1:20,1694476800,0.243,-0.83055556,0.14113986,ASE,EQUITY,AMPE,AMPE,"Ampio Pharmaceuticals, Inc.","Ampio Pharmaceuticals, Inc.",1270042200,America/New_York,EDT,4c3db42c-6886-3221-8b5a-40ddd23eb155,finmb_84650489,-14400000,4.27,3.0,hold,6987000,9.253,-13664000,448000,3.354,3.667,6.829,-0.49251997,-1.04888,-11049000,-15937000,0.0,0.0,0.0,USD,
2,373 Inverness Parkway,Suite 200,Englewood,CO,80112,United States,720 437 6500,720 437 6501,https://ampiopharma.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.",8,"{'maxAge': 1, 'name': 'Mr. Daniel G. Stokely CPA, CPA', 'age': 58, 'title': 'CFO, Corp. Sec. & Treasurer', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 346725, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,4.17,4.18,4.0401,4.38,4.17,4.18,4.0401,4.38,0.0,1.779391,-47.444443,33065,33065,29213,47947,47947,4.11,4.4,800,1100,3224166,3.354,27.51,4.3597,5.003753,0.0,0.0,USD,-3314829,0.0,689270,755074,21291,13716,1690761600,1693440000,0.028199999,0.4,0.028900001,755074,8.687,0.49153906,1672444800,1703980800,1688083200,-13980000,-118.32,-0.09,1:20,1694476800,0.243,-0.83055556,0.14113986,ASE,EQUITY,AMPE,AMPE,"Ampio Pharmaceuticals, Inc.","Ampio Pharmaceuticals, Inc.",1270042200,America/New_York,EDT,4c3db42c-6886-3221-8b5a-40ddd23eb155,finmb_84650489,-14400000,4.27,3.0,hold,6987000,9.253,-13664000,448000,3.354,3.667,6.829,-0.49251997,-1.04888,-11049000,-15937000,0.0,0.0,0.0,USD,
3,373 Inverness Parkway,Suite 200,Englewood,CO,80112,United States,720 437 6500,720 437 6501,https://ampiopharma.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.",8,"{'maxAge': 1, 'name': 'April  Ramirez', 'title': 'Clinical Trial Mang.', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,4.17,4.18,4.0401,4.38,4.17,4.18,4.0401,4.38,0.0,1.779391,-47.444443,33065,33065,29213,47947,47947,4.11,4.4,800,1100,3224166,3.354,27.51,4.3597,5.003753,0.0,0.0,USD,-3314829,0.0,689270,755074,21291,13716,1690761600,1693440000,0.028199999,0.4,0.028900001,755074,8.687,0.49153906,1672444800,1703980800,1688083200,-13980000,-118.32,-0.09,1:20,1694476800,0.243,-0.83055556,0.14113986,ASE,EQUITY,AMPE,AMPE,"Ampio Pharmaceuticals, Inc.","Ampio Pharmaceuticals, Inc.",1270042200,America/New_York,EDT,4c3db42c-6886-3221-8b5a-40ddd23eb155,finmb_84650489,-14400000,4.27,3.0,hold,6987000,9.253,-13664000,448000,3.354,3.667,6.829,-0.49251997,-1.04888,-11049000,-15937000,0.0,0.0,0.0,USD,
